Amgen-Horizon: The FTC's First Litigated Pharmaceutical Merger Challenge in 14 Years and First Conglomerate Merger Challenge in Decades | Wilson Sonsini Goodrich & Rosati

On May 17, 2023, the Federal Trade Commission (FTC) challenged Amgen Inc.’s (Amgen) proposed acquisition of Horizon Therapeutics plc (Horizon). The complaint is significant in three...

Related Keywords

Philadelphia ,Pennsylvania ,United States ,Lina Khan ,Elizabeth Warren ,Wilson Sonsini Goodrich Rosati ,Clorox ,Regeneron Pharms Inc ,Amgen Inc ,Philadelphia National Bank ,Drug Administration ,Us Department Of Justice ,Amgen ,Us Supreme Court ,Wilson Sonsini Goodrich ,Federal Trade Commission ,Horizon Therapeutics ,Chair Lina Khan ,Time Warner ,Second Request ,Capitol Hill ,Senator Elizabeth Warren ,National Bank ,Regeneron Pharms ,Chair Khan ,Commissioner Rebecca Slaughter ,Acting Chair ,